Manchester Molecular Pathology Innovation Centre (MMPathIC) has developed a virtual pipeline model for the development of novel biomarkers and technologies; offering a simplified and streamlined pathway for market access.
An opportunity to discuss and develop understanding around risk factors influencing disease occurrence and re-occurrence.
Members of the Hearing Health theme have contributed to the new NICE guideline for assessment and management of adult hearing loss.
A new genetic test that could identify the risk of, and therefore help to avoid permanent antibiotic-related hearing loss in newborn babies is being developed in Manchester, UK.
The Manchester BRC and CRF have been chosen as one of 13 centres around England which will contribute to the new NIHR BioResource for Translational Research in Common and Rare Diseases.
This interactive workshop is an opportunity to learn more about the use of data to predict health risks and outcomes for clinical pathway redesign and disease prevention.
The NIHR Manchester BRC, in collaboration with the NIHR Manchester Clinical Research Facility (CRF) and supported by Corridor Manchester and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it!
At the start of the year a panel of international experts from academia and industry visited Manchester for the first annual strategy workshop.